pharmaphorum

JANUARY 31, 2022

People with long-lasting symptoms of breathlessness after COVID-19 infection may have damage to their lungs that does not show up using routine diagnostic scans, according to a small UK study. The researchers from Oxford, Sheffield, Cardiff and Manchester universities used a new form of diagnostic that involves patients breathing in the inert gas xenon whilst undergoing an MRI scan, which allows them to gauge how well gases like oxygen are being transferred from the lungs to blood vessels.

110

110

Outsourcing Pharma

JANUARY 31, 2022

The Stoneygate and Kidney Research UK Alport Research Hub aims to accelerate research and develop treatments for Alport syndrome, a rare genetic disorder.

98

98

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation. Access to and awareness of vaccines is more important than ever, especially in a globally connected world where outbreaks cannot easily be confined to a limited area.

Vaccines 91

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 91

Fierce Healthcare

JANUARY 31, 2022

RPM tech provider Athelas hits unicorn status with $132M raised for chronic care management. rtorrence. Mon, 01/31/2022 - 10:10.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 31, 2022

Daiichi Sankyo has stepped up its efforts to bring a Japanese COVID-19 vaccine to patients, starting a new clinical trial of its mRNA-based candidate DS-5670 that focuses on its use as a booster dose. The Japanese group says it hopes to complete clinical development of the vaccine and bring it to market in Japan before the end of the year. Daiichi Sankyo started human testing of the shot in March 2021, with preliminary results in studies involving 142 healthy adults showing no safety concerns af

Vaccines 88

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 88

Fierce Healthcare

JANUARY 31, 2022

Kaufman Hall: Hospital financials fared better across 2021 but still lag pre-pandemic numbers. dmuoio. Mon, 01/31/2022 - 12:06.

Hospitals 105

Hospitals 105

Fierce Healthcare

JANUARY 31, 2022

Oncologists worry they may have to reduce staff or enhanced care after payment model ends in June: survey. rking. Mon, 01/31/2022 - 12:40.

98

98

Outsourcing Pharma

JANUARY 31, 2022

The pharma firm has announced the agency has approved the companyâs investigational new drug application for its Phase II trial of pemvidutide for obesity.

FDA 69

FDA 69

Fierce Healthcare

JANUARY 31, 2022

Oncologists worry they may have to reduce staff or enhanced care after payment model ends in June: survey. rking. Mon, 01/31/2022 - 12:13.

98

98

Policy Prescription

JANUARY 31, 2022

This post should serve as the beginning of a serious inquiry into the failure of U.S. state boards of pharmacy to properly regulate pharmacies that irresponsibly and too often illegally profited from opioid drug sales to patients. Sociologist Elizabeth Chiarello writes , “Boards have a duty to protect the public, but because they are mostly comprised of professionals whose common interests may conflict with those of the public, their ability to do so is questionable.

FDA 52

FDA 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JANUARY 31, 2022

RPM tech provider Athelas hits unicorn status with $132M raised for chronic care management. rtorrence. Mon, 01/31/2022 - 10:12.

98

98

Fuld

JANUARY 31, 2022

The past two years have been a time of profound disruption and change which has impacted us all on many different levels. For Fuld & Company, 2021 was also a time of rapid growth, and as we begin 2022, we are excited to announce the launch of a suite of new services to bring even greater depth to our Competitive Intelligence , Market Insights and Strategic Planning offerings.

52

52

Fierce Healthcare

JANUARY 31, 2022

Kaufman Hall: Hospital financials fared better across 2021 but still lag pre-pandemic numbers. dmuoio. Mon, 01/31/2022 - 11:58.

Hospitals 98

Hospitals 98

pharmaphorum

JANUARY 31, 2022

Glooko has made a name for itself in digital health circles with its data management tools for diabetes patients, and has now added artificial intelligence capabilities with an agreement to acquire xbird. The deal centres around Berlin, Germany-based xbird’s “just In time adaptive intervention” technologies – or JITAIs – which uses AI to analyse and categorise patient behaviour patterns based on mobile data inputs, and assess health risks.

FDA 52

FDA 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JANUARY 31, 2022

Laguna Health adds new role to build out custom patient engagement platform. agliadkovskaya. Mon, 01/31/2022 - 12:31.

97

97

pharmaphorum

JANUARY 31, 2022

Chinese digital health firm ETAO International will go public via a merger with a blank cheque company that will value it at around $2.5 billion. The deal with special purpose acquisition company (SPAC) Mountain Crest Acquisition Corp III (MCAE) will give the five-year-old telehealth group up to $304 million in gross proceeds, bolstered by a $250 million private round from China SME Investment Group.

Hospitals 52

Hospitals 52

Fierce Healthcare

JANUARY 31, 2022

Laguna Health adds new role to build out custom patient engagement platform. agliadkovskaya. Mon, 01/31/2022 - 12:23.

96

96

pharmaphorum

JANUARY 31, 2022

Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content. Pharma companies created 3.5 times more digital content than print in 2020, driven by the growing prevalence of digital channels during the early stages of the Covid-19 pandemic. Yet, two years on, marketers still face mounting pressure to accelerate production and deliver greater volumes of content across multiple channels, often without the supp

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Fierce Healthcare

JANUARY 31, 2022

Komodo Health notches another major partnership as it gears up to go public. hlandi. Mon, 01/31/2022 - 09:14.

98

98

pharmaphorum

JANUARY 31, 2022

Pfizer has called time on its alliance with Ionis for cholesterol-lowering therapy vupanorsen, after a review of phase 2b data raised some questions about the antisense drug’s efficacy and safety. It’s a setback to Pfizer’s late-stage pipeline, given that at one point the company was projecting $3 billion in potential sales for vupanorsen, which targets ANGPTL3 protein and is playing catch-up in the category with Regeneron’s already-marketed Evkeeza (evinacumab).

Vaccines 52

Vaccines FDA Hospitals 52

Fierce Healthcare

JANUARY 31, 2022

Editor's Corner: Fierce Healthcare gets a fierce makeover. hlandi. Mon, 01/31/2022 - 10:47.

98

98

Pharma Times

JANUARY 31, 2022

Positive news for children aged six to 11 as Dupixent offers improved asthma treatment

44

44

Fierce Healthcare

JANUARY 31, 2022

Cigna taps new exec to lead its US Government Business. pminemyer. Mon, 01/31/2022 - 10:53.

98

98

Pharma Times

JANUARY 31, 2022

Vulnerable people at risk from COVID-19 are set to have access to game-changing Pfizer antiviral

37

37

Fierce Healthcare

JANUARY 31, 2022

Cigna taps new exec to lead its US Government Business. pminemyer. Mon, 01/31/2022 - 10:56.

75

75

Fierce Healthcare

JANUARY 31, 2022

Healthcare’s Imperative for Long-Game Leadership. mwen. Mon, 01/31/2022 - 14:00.

58

58

Fierce Healthcare

JANUARY 31, 2022

Optum: 3 (more) drugs in the pipeline payers should be watching. pminemyer. Mon, 01/31/2022 - 10:37.

52

52

Fierce Healthcare

JANUARY 31, 2022

Optum: 3 (more) drugs in the pipeline payers should be watching. pminemyer. Mon, 01/31/2022 - 10:39.

45

45